Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-04-26 Kulkarni Samarth Chief Business Officer Sale −3,275 $16.74 $55K 134,047
2017-04-26 Kulkarni Samarth Chief Business Officer Exercise or conversion · Stock Options (Right to Buy) −3,275 296,764
2017-04-26 Dylan-Hyde Tyler Chief Legal Officer Sale −3,200 $16.76 $54K 180,495
2017-04-25 Dylan-Hyde Tyler Chief Legal Officer Sale −4,800 $16.87 $81K 183,695
2017-04-25 Kulkarni Samarth Chief Business Officer Exercise or conversion +5,115 $1.81 $9K 139,162
2017-04-25 Kulkarni Samarth Chief Business Officer Sale −5,115 $16.87 $86K 134,047
2017-04-25 Kulkarni Samarth Chief Business Officer Exercise or conversion · Stock Options (Right to Buy) −5,115 300,039
2017-04-24 Dylan-Hyde Tyler Chief Legal Officer Sale −3,522 $16.44 $58K 188,495
2017-04-24 Kulkarni Samarth Chief Business Officer Exercise or conversion +3,500 $1.81 $6K 137,547
2017-04-24 Kulkarni Samarth Chief Business Officer Sale −3,500 $16.46 $58K 134,047
2017-04-24 Kulkarni Samarth Chief Business Officer Exercise or conversion · Stock Options (Right to Buy) −3,500 305,154
2017-04-21 Dylan-Hyde Tyler Chief Legal Officer Sale −3,010 $17.02 $51K 192,017
2017-04-21 Kulkarni Samarth Chief Business Officer Exercise or conversion +3,000 $1.81 $5K 137,047
2017-04-21 Kulkarni Samarth Chief Business Officer Sale −3,000 $17.01 $51K 134,047
2017-04-21 Kulkarni Samarth Chief Business Officer Exercise or conversion · Stock Options (Right to Buy) −3,000 308,654
2017-04-20 Novak Rodger Chief Executive Officer Exercise or conversion +2,294 $1.81 $4K 1,217,299
2017-04-20 Novak Rodger Chief Executive Officer Sale −2,294 $17.37 $40K 1,215,005
2017-04-20 Novak Rodger Chief Executive Officer Exercise or conversion · Stock Options (Right to Buy) −2,294 218,093
2017-04-20 Kulkarni Samarth Chief Business Officer Exercise or conversion +2,800 $1.81 $5K 136,847
2017-04-20 Kulkarni Samarth Chief Business Officer Sale −2,800 $17.36 $49K 134,047

Page 66 of 74 · 1,471 trades